Inao T, Okada K, Yang Y, Yokota I. Simulation studies on the estimation of sensitivity and specificity in the absence of a gold standard and with rare positive frequencies. Commun Stat Simul Comput. [Epub ahead of print]
Inao T, Yokota I. Exact sequential single-arm trial design with curtailment for binary endpoint. ENAR 2023 Spring Meeting. 2023/3/19. Nashville, TN. Fuyama K, Yokota I. Probabilistic index for survival analysis using landmark time, clinically significant differences, and multiple prioritized endpoints: a simulation study. ENAR 2023 Spring Meeting. 2023/3/19. Nashville, TN.
Nakakubo S*, Unoki Y*, Kitajima K, Terada M, Gatanaga H, Ohmagari N, Yokota I, Konno S. Serum Lactate Dehydrogenase Level One Week after Admission Is the Strongest Predictor of Prognosis of COVID-19: A Large Observational Study Using the COVID-19 Registry Japan. Viruses. 2023; 15(3):671. https://doi.org/10.3390/v15030671 * Equally contributed
Fuyama K, Ogawa M, Mizusawa J, Kanemitsu Y, Fujita S, Kawahara T, Sakamaki K, Oba K. Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons. Stat Med. 2023 Feb 27. doi: 10.1002/sim.9690. Epub ahead of print. PMID: 36849124.